Live feed
Filing
SCHEDULE 13G
SCHEDULE 13G0001689655-24-000020·Walters William T
Schedule 13G ownership disclosure
Zentalis Pharmaceuticals, Inc.
Common Stock, $0.001 par value per share · CUSIP: 98943L107
Event date: 2024-12-03
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Walters William T
Shares: 4,000,000.00 · Class: 5.6%
- WALTERS GROUP
Shares: 4,000,000.00 · Class: 5.6%
- Walters, Susan B.
Shares: 4,000,000.00 · Class: 5.6%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001689655-24-000020
- Form type
- SCHEDULE 13G
- Filer
- Walters William T
- CIK
- CIK 1689655
- Filed
- Dec 10, 2024
- Reporting period
- Dec 03, 2024
- Description
- Schedule 13G beneficial ownership